Delivery Order SPE2DB22D1017-SPE2DB23FG3DA

Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $882
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $918 delivery order to Amerisourcebergen Drug Corporation for 4561631459 OTREXUP 20 MG/0.4 ML auto-injectors. The firm fixed-price order calls for Amerisourcebergen to deliver 0.4mL auto-injection devices to a location in Conshohocken, Pennsylvania by July 31, 2023 in support of DLA programs. No set-aside designation or subcontractors were identified. DLA manages the global supply chain for the Department of Defense, ensuring products like specialty...
The Defense Logistics Agency awarded a $918 delivery order to Amerisourcebergen Drug Corporation for 4561947289 OTREXUP 20 MG/0.4 ML auto-injectors. The firm fixed-price order calls for Amerisourcebergen to deliver 0.4mL auto-injection devices to a location in Conshohocken, Pennsylvania by August 28, 2023 in support of DLA programs. As a top pharmaceutical supplier, Amerisourcebergen will likely distribute the auto-injectors to military treatment facilities and deploying forces. No...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,622.71, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML pharmaceuticals. The contract has a potential value of $5,026.04 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order contract is part of a larger indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $2,473.13 and a period of performance through March 18, 2024. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.06, is for the supply of OTREXUP 12.5 MG/0.4 ML AUTOINJ 0.4ML, a medical product. It is a firm fixed-price delivery order contract with a period of performance through January 22, 2024. The contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp holds a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,272.11 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00, to deliver a comprehensive range of medications and medical supplies to support the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,079.54, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for this award is March 17, 2025. This contract award is not designated as a set-aside....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,774.92 firm fixed-price delivery order is for the OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML pharmaceutical product. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML. The contract has a ceiling value of $5,833.20 and is a firm fixed price delivery order running through March 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB23FG3DA
    Delivery Order

The Defense Logistics Agency awarded a $881.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562125900 OTREXUP 25 MG/0.4 ML auto-injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of DLA and Department of Defense requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 11 to September 12, 2023. No set-aside designation or subcontracting arrangements were identified. The delivery order supports DLA's mission to provide medical supplies to military treatment facilities and contingency operations worldwide.

Generated 12/20/23, 4:12 PM